We advised AIMM Therapeutics, an Amsterdam based biotech company, in relation to its most recent financing round. AIMM Therapeutics develops antibody-based treatments by discovering the most effective antibodies against cancer and infectious diseases that are obtained from individuals who have overcome disease or from immunized animals.
We advised the shareholders of PhoeniX Software, including Twente Technology Fund, on the sale of all shares in PhoeniX Software to Synopsys, Inc. PhoeniX Software is a global supplier of photonic chip design solutions. With the acquisition, Synopsys is the leading provider of photonic integrated circuit design automation solutions for a wide range of application requirements ranging from data communications to sensors and biomedical devices.
We advised Quantib in its EUR 4.5 million investment round lead by Holland Capital and InnovationQuarter. Quantib develops Machine Learning (ML) applications for medical imaging analyses, allowing physicians and researchers to make more efficient and more accurate diagnoses. The investment supports Quantib with her international scale-up ambitions.
We advised SET Ventures with its investment in Elmodis, an industrial internet of things start-up based in Poland. SET Ventures invested US$ 4.9 million together with Intel Capital and Innovation Nest. Elmodis provides an integrated hardware and cloud based software solution that monitors the performance of industrial machines powered by electric motors in real time.
We advised the parties involved with the investment by SET Ventures and henQ in Energyworx. Energyworx develops a SaaS-based platform for energy data management and energy intelligence solutions that help utility companies navigate and monetize the energy transition.